Cytokinetics Inc

Cytokinetics Inc

CYTK · NASDAQ
CYTK · NASDAQ
50.61
USD-0.92-1.78%

Data

Tickers

Título

Fonte

    Cytokinetics jumps amid renewed takeover speculation

    SeekingAlpha

      Cytokinetics says potential acquirer walked away

      SeekingAlpha

        Cytokinetics gains amid renewed takeover speculation

        SeekingAlpha

          Cytokinetics drifts lower as CEO touts standalone strategy

          SeekingAlpha

            Cytokinetics seesaws as CEO says not conducting a sales process

            SeekingAlpha

              Cytokinetics weakness a buying opportunity, Truist says

              SeekingAlpha

                UBS cuts Cytokinetics to neutral, sees takeout valuation at $105

                SeekingAlpha

                  Amgen may be evaluating Cytokinetics bid; CYTK wants $130-$145 a share - report

                  SeekingAlpha

                    Novartis said to have backed away from a deal for Cytokinetics

                    SeekingAlpha

                      Cytokinetics plunges amid no deal announcement as JPMorgan conf set to end

                      SeekingAlpha

                        Cytokinetics drops as Novartis CEO says the company is focused on bolt-on deals

                        SeekingAlpha

                          Cytokinetics soars on report Novartis in advanced talks to purchase

                          SeekingAlpha

                            Cytokinetics falls amid no sale announcement

                            SeekingAlpha

                              Cytokinetics may be worth $90+ a share in potential deal amid Phase 3 data - UFP

                              SeekingAlpha

                                Cytokinetics gains amid report of Novartis, AstraZeneca takeover interest

                                SeekingAlpha

                                  Cytokinetics surges amid report of takeover interest

                                  SeekingAlpha

                                    Cytokinetics speculated to be a takeover target

                                    SeekingAlpha

                                      U.S. FDA declines to approve Cytokinetics' heart drug https://t.co/buWXoPeNew https://t.co/RCeJNTtuLE

                                      Reuters
                                      @Reuters

                                        U.S. FDA declines to approve Cytokinetics' heart drug https://t.co/wKqbkQJFhk https://t.co/dQBJyQXOrG

                                        Reuters
                                        @Reuters

                                          Cytokinetics' heart drug fails to secure FDA panel's support https://t.co/v6I2ZioEXi https://t.co/Tr8JroRHJ8

                                          Reuters
                                          @Reuters

                                          Perguntas Frequentes

                                          Qual é o preço da ação de Cytokinetics hoje?

                                          Qual é o código de ação de Cytokinetics?

                                          O preço da ação de CYTK está subindo?

                                          Qual é a recomendação dos analistas para CYTK?

                                          Qual é o valor de mercado de CYTK?

                                          CYTK divulga relatórios financeiros?

                                          Quando será a próxima data de resultados de CYTK?

                                          Quais foram os lucros de CYTK no último trimestre?

                                          Qual foi a receita de CYTK no último trimestre?

                                          Qual foi o lucro líquido de CYTK no último trimestre?

                                          CYTK paga dividendos?

                                          Quantos funcionários CYTK tem?

                                          O que é o EBITDA de CYTK?

                                          Como comprar ações de CYTK?

                                          Devo investir nas ações da CYTK?